Overview

Prevention of Periprosthetic Bone Loss After Total Hip Replacement by Annual Bisphosphonate Therapy

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
Periprosthetic bone loss caused by stress-shielding effect, a phenomenon of bone atrophy under mechanical unloading after THR implantation, further compromises the longevity of implant. The prospective randomized study is aimed to investigate the periprosthetic bone loss after primary total hip replacements.
Phase:
Phase 3
Details
Lead Sponsor:
Mel Shiuann-Sheng Lee
Collaborator:
Novartis
Treatments:
Diphosphonates
Zoledronic Acid